Skip to main content Skip to main navigation Skip to page-level navigation Go to the Disability Resource Centre Website Go to the DRC Booking Accommodation Portal Go to the Inclusive Technology Lab Website
The University of British Columbia
The University of British Columbia Okanagan campus
UBC Okanagan News
  • Research
  • People
    • Student Profile
    • Faculty Profile
    • Alumni Spotlight
  • Campus Life
    • Campus News
    • Student Life
    • Teaching & Learning
  • Community Engagement
  • About the Collection
    • Stories for Media
  • UBCO Events
  • Search All Stories
Home / 2022 / December / 12 / Tiny receptors might be key to preventing progression of brain cancer
Health, Research

Tiny receptors might be key to preventing progression of brain cancer

UBCO research aims to understand the aggressive spread of brain tumours

December 12, 2022

Brain cells with the focus put on astrocytes

Star-shaped astrocytes, shown red in this image, extend cellular projections like tentacles to communicate with neighbouring brain cells. Once astrocytes become cancerous, the projections become longer, and their networks become more complex, invading different areas of the brain.

Brain cancer. It’s the diagnosis no one wants to hear.

Patients with high-grade gliomas, or tumours in the brain and spinal cord, have an average life expectancy of a mere 12 to 16 months. Not only do tumours in the brain spread more aggressively than in other tissues, but these tumours are also resistant to chemotherapy and have a high probability to recur after surgical removal.

Now UBC Okanagan researchers are working to better understand the development and rapid growth of cancerous cells in the brain.

Sessional Lecturer Dr. Mitra Tabatabaee and Dr. Fred Menard, Associate Professor in Chemistry, Biochemistry and Molecular Biology at UBCO, examined astrocytoma, a cancer that begins in astrocytes—cells that support nerve cells.

Currently, astrocytoma is highly fatal with no effective treatment.

Their research, recently published in Cells, reviews the potential role of an imbalance of glutamate—a neurotransmitter that stimulates nerve cells—in astrocytoma progression. It suggests that several receptors not previously considered in brain cancer research might be crucial to the cancerous growth of astrocytoma.

“Astrocytoma spreads throughout the brain quickly, and there is no treatment,” says Dr. Tabatabaee. “There’s not enough information about the development of astrocytoma, which is one of the main reasons for the lack of effective treatment. We need to know first the molecular mechanism of what’s happening.”

Star-shaped astrocytes extend cellular projections like tentacles that stretch to communicate with their neighbouring cells. Once these astrocytes become cancerous, the projections become longer, and their networks become more complex, invading different areas of the brain. How far they extend in the brain is strongly correlated with the cancer’s aggressivity and its resistance to treatment.

“If some extra-long cell projections are left behind during surgery, the tumour can grow back,” says Dr. Tabatabaee.

A suspected cause of this uncontrolled growth of cellular processes is elevated levels of glutamate. When astrocytes sense glutamate, the concentration of calcium rises inside the cell. Since calcium is also necessary for growing cellular projections, the glutamate receptors that affect the calcium inside astrocytes are prime suspects for the abnormal growth of astrocytoma cells.

By studying astrocytoma cells, Dr. Tabatabaee and Dr. Menard identified a glutamate receptor and two other molecular contributors crucial in extending the projections of these cancerous cells.

With further study, researchers believe that these overlooked receptors can serve as targets for designing more effective chemotherapies and open up new avenues to halt the progression of this aggressive and often fatal cancer.

“Studying and targeting these specific receptors, may pave the way to understand how we can stop infiltration of the disease throughout the brain and prevent the tumour growth,” says Dr. Tabatabaee.

Media Contact

Patty Wellborn
E-mail: patty.wellborn@ubc.ca

Content type: Media Release
More content from: Biology, Chemistry, Irving K Barber Faculty of Science

Trending Stories

  • How one student connects AI innovation to wildfire research
  • Putting community, students and research on the same track
  • Psychedelic mushroom microdoses can improve mood, mental health
  • Robotics, AI advancing wildfire, agricultural research at UBCO
  • UBCO professor researches electric passenger light rail for Okanagan Valley
All Stories
Contact Media Relations

About UBC Okanagan

UBC’s Okanagan campus is an innovative hub for research and learning founded in partnership with local Indigenous peoples, the Syilx Okanagan Nation, in whose traditional, ancestral and unceded territory the campus resides. The most established and influential global rankings all consistently place UBC in the top five per cent of universities in the world, and among the top three Canadian universities.

The Okanagan campus combines a globally recognized UBC education with a tight-knit and entrepreneurial community that welcomes students and faculty from around the world in British Columbia’s stunning Okanagan Valley. For more visit ok.ubc.ca.

Discover more about UBC Okanagan

Find a Program Admissions Book a Tour UBCO Facts
UBC Okanagan Campus News, University Relations

Innovation Precinct Annexation 1 (IA1)
3505 Spectrum Court
Kelowna, BC Canada V1V 2Z1

We respectfully acknowledge the Syilx Okanagan Nation and their peoples, in whose traditional, ancestral, unceded territory UBC Okanagan is situated.

 

Search all stories

Subscribe to receive news by email

Visit UBC's Vancouver news room

Global and Admin Messages

News

Okanagan Campus

TikTok icon Linkedin icon

UBC Okanagan News
Okanagan Campus
3333 University Way
Kelowna, BC Canada V1V 1V7
Find us on
  
Back to top
The University of British Columbia
  • Emergency Procedures |
  • Terms of Use |
  • Copyright |
  • Accessibility